The Legal Intelligencer TLI Life Sciences and Pharamceuticals October 6 2015.pdf : Page 1

  |  Special Section  |  October 2015 Life Sciences and Pharmaceuticals 2 IP Considerations for Early-Stage Life Science Companies 3 Pitfalls for Drug Sponsors During Clinical Trials 4 The Sunshine Act and Publicly Available Payment Data 5 An Update on Digital Health IP Protection 6 Why You Should Think Before Using Generic Drugs

Next Page

Publication List
Using a screen reader? Click Here